Label: MEPERIDINE HCL injection, solution
-
Contains inactivated NDC Code(s)
NDC Code(s): 52533-042-04 - Packager: Cantrell Drug Company
- Category: HUMAN PRESCRIPTION DRUG LABEL
- DEA Schedule: CII
- Marketing Status: unapproved drug other
DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
Drug Label Information
Updated April 30, 2014
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- PRINCIPAL DISPLAY PANEL
- SPL UNCLASSIFIED SECTION
-
INGREDIENTS AND APPEARANCE
MEPERIDINE HCL
meperidine hcl injection, solutionProduct Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:52533-042 Route of Administration INTRAVENOUS DEA Schedule CII Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength MEPERIDINE HYDROCHLORIDE (UNII: N8E7F7Q170) (MEPERIDINE - UNII:9E338QE28F) MEPERIDINE HYDROCHLORIDE 10 mg in 1 mL Inactive Ingredients Ingredient Name Strength Sodium Chloride (UNII: 451W47IQ8X) 9 mg in 1 mL WATER (UNII: 059QF0KO0R) Other Ingredients Ingredient Kind Ingredient Name Quantity May contain HYDROCHLORIC ACID (UNII: QTT17582CB) May contain SODIUM HYDROXIDE (UNII: 55X04QC32I) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:52533-042-04 50 mL in 1 SYRINGE, PLASTIC Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 01/23/2012 Labeler - Cantrell Drug Company (035545763) Establishment Name Address ID/FEI Business Operations Cantrell Drug Company 035545763 manufacture(52533-042) , human drug compounding outsourcing facility(52533-042) (No intent to compound 506E (drug shortage) drugs), (Not compounding from bulk ingredient)
